These reported S2-specific mAbs isolated after heterologous coronavirus S protein immunization in mice or from COVID-19 convalescent serum all had cross-reactivity with SARS-CoV-1 and/or other human-infecting coronaviruses. This evidence concerns the gene PROS1 and COVID-19.